Multimorbidity, Disadvantage, and Trends in Disability-Free Life Expectancy: The CFAS Studies. (16th December 2020)

• Record Type: Journal Article
• Authors: Kingston, Andrew; Bennett, Holly; Robinson, Louise; Corner, Lynne; Brayne, Carol; Matthews, Fiona; Jagger, Carol
• Is Part Of: Innovation in aging. Volume 4(2020)Supplement 1
• Page Start: 641
• Page End: 641
• Publication Date: 2020-12-16
• Subjects: Aging -- Periodicals; Gerontology -- Periodicals; 612.67
• DOI: 10.1093/geroni/igaa057.2200
• Languages: English
• ISSNs: 2399-5300

Abstract

Abstract: The combined contribution of multi-morbidity and socio-economic position (SEP) to trends in disability free life expectancy (DFLE) is unknown. We use longitudinal data from the Cognitive Function and Ageing Studies (CFAS I: 1991; CFAS II: 2011), with two year follow up. Disability was defined as difficulty in activities of daily living, and SEP as area-level deprivation. Multi-morbidity was constructed from nine self-reported health conditions and categorised as 0-1, 2-3, 4+ diseases. In 1991 and 2011, shorter total and disability-free years were associated with greater multi-morbidity. Between 1991 and 2011, gains in life expectancy and DFLE were observed at all levels of multi-morbidity, the greatest gain in DFLE being 4 years for men with 0-1 diseases. As multi-morbidity is more prevalent in more disadvantaged groups, further analyses will investigate whether SEP differences remain at all levels of multi-morbidity.